{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T13:37:40Z","timestamp":1794663460121,"version":"4.9.1"},"reference-count":18,"publisher":"Oxford University Press (OUP)","issue":"42","license":[{"start":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T00:00:00Z","timestamp":1754956800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Philips IGDT"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,11,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background and Aims<\/jats:title>\n                    <jats:p>Invasive coronary function testing (CFT) identifies coronary vasomotor disorders in up to 90% of patients with angina with non-obstructive coronary arteries (ANOCA). The ILIAS ANOCA trial hypothesized that routine ad hoc CFT would be feasible, safe, and effective in providing an early, comprehensive diagnosis. Additionally, it was anticipated that combining CFT with a disease-specific treatment protocol would significantly improve quality of life in ANOCA patients compared with standard care.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>After excluding patients with obstructive coronary artery disease (CAD) during clinically indicated invasive coronary angiography (ICA), eligible patients underwent CFT and were randomized to either the standard care group, where CFT results remained blinded, or the intervention group, where CFT results were disclosed along with a tailored medical therapy protocol. The primary outcome was the mean difference in the within-subject change in Seattle Angina Questionnaire summary score (SAQSS) between groups from baseline to a follow-up of 6\u2005months. The trial is registered with the International Clinical Trials Registry Platform (NL-OMON20739).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 255 patients consented, of whom 153 patients (60%) without CAD underwent CFT and were randomized 1:1 to the standard care (n = 76) or intervention group (n = 77). All CFT procedures were successful without adverse events. A vasomotor disorder was identified in 120 patients (78%). At 6-month follow-up, the SAQSS improved significantly in the intervention group compared with the control group, with an intervention effect of 9.4\u2005units (95% confidence interval 3.9\u201314.9, P = .001). There were no major adverse cardiac events at the 6-month follow-up.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Routine CFT during the initial ICA was feasible, safe, and had high diagnostic yield. Implementing a pragmatic CFT protocol combined with a disease-specific treatment protocol significantly improved disease-related quality of life in patients with ANOCA compared with standard care.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/eurheartj\/ehaf580","type":"journal-article","created":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T11:46:24Z","timestamp":1753443984000},"page":"4396-4406","source":"Crossref","is-referenced-by-count":52,"title":["Coronary function testing vs angiography alone to guide treatment of angina with non-obstructive coronary arteries: the ILIAS ANOCA trial"],"prefix":"10.1093","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1515-9623","authenticated-orcid":false,"given":"Coen K M","family":"Boerhout","sequence":"first","affiliation":[{"name":"Department of Cardiology, Amsterdam University Medical Center, Location AMC , Amsterdam ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-1107-2513","authenticated-orcid":false,"given":"Hanae F","family":"Namba","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Amsterdam University Medical Center, Location AMC , Amsterdam ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tommy","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, University Medical Center Utrecht , Heidelberglaan 100, 3584 CX Utrecht ,","place":["The Netherlands"]},{"name":"HartKliniek Rijswijk , Rijswijk ,","place":["The Netherlands"]},{"name":"HartKliniek Bilthoven , Bilthoven ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcel A M","family":"Beijk","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Amsterdam University Medical Center, Location AMC , Amsterdam ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9284-7967","authenticated-orcid":false,"given":"Peter","family":"Damman","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Radboud University Medical Center , Nijmegen ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5421-5205","authenticated-orcid":false,"given":"Martijn","family":"Meuwissen","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Amphia Hospital , Breda ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2253-2828","authenticated-orcid":false,"given":"Peter","family":"Ong","sequence":"additional","affiliation":[{"name":"Department of Cardiology and Angiology, Robert Bosch Krankenhaus , Stuttgart ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Udo","family":"Sechtem","sequence":"additional","affiliation":[{"name":"Department of Cardiology and Angiology, Robert Bosch Krankenhaus , Stuttgart ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5241-7105","authenticated-orcid":false,"given":"Yolande","family":"Appelman","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Amsterdam University Medical Center, Location VUMC , Amsterdam ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4547-8636","authenticated-orcid":false,"given":"Colin","family":"Berry","sequence":"additional","affiliation":[{"name":"British Heart Foundation Glasgow Cardiovascular Research Centre, University of Glasgow , Glasgow ,","place":["UK"]},{"name":"Department of Cardiology, Golden Jubilee National Hospital , Clydebank ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4932-0112","authenticated-orcid":false,"given":"Javier","family":"Escaned","sequence":"additional","affiliation":[{"name":"Cardiology Department, Hospital Cl\u00ednico San Carlos, IDISSC Universidad Complutense de Madrid, Madrid ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9446-5313","authenticated-orcid":false,"given":"Amir","family":"Lerman","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Mayo Clinic , Rochester, MN ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy D","family":"Henry","sequence":"additional","affiliation":[{"name":"The Carl and Edyth Lindner Research Center at the Christ Hospital , Cincinnati, OH ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2713-686X","authenticated-orcid":false,"given":"Pim","family":"van der Harst","sequence":"additional","affiliation":[{"name":"Department of Cardiology, University Medical Center Utrecht , Heidelberglaan 100, 3584 CX Utrecht ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronak","family":"Delewi","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Amsterdam University Medical Center, Location AMC , Amsterdam ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan J","family":"Piek","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Amsterdam University Medical Center, Location AMC , Amsterdam ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0682-0619","authenticated-orcid":false,"given":"Tim P","family":"van de Hoef","sequence":"additional","affiliation":[{"name":"Department of Cardiology, University Medical Center Utrecht , Heidelberglaan 100, 3584 CX Utrecht ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,8,12]]},"reference":[{"key":"2025110902421959900_ehaf580-B1","doi-asserted-by":"publisher","first-page":"3504","DOI":"10.1093\/eurheartj\/ehaa503","article-title":"An EAPCI expert consensus document on ischaemia with non-obstructive coronary arteries in collaboration with European Society of Cardiology Working Group on Coronary Pathophysiology & Microcirculation endorsed by Coronary Vasomotor Disorders International Study Group","volume":"41","author":"Kunadian","year":"2020","journal-title":"Eur Heart J"},{"key":"2025110902421959900_ehaf580-B2","doi-asserted-by":"publisher","first-page":"3415","DOI":"10.1093\/eurheartj\/ehae177","article-title":"2024 ESC Guidelines for the management of chronic coronary syndromes","volume":"45","author":"Vrints","year":"2024","journal-title":"Eur Heart J"},{"key":"2025110902421959900_ehaf580-B3","doi-asserted-by":"publisher","first-page":"E012017","DOI":"10.1161\/CIRCINTERVENTIONS.122.012017","article-title":"Presence of coronary endothelial dysfunction, coronary vasospasm, and adenosine-mediated vasodilatory disorders in patients with ischemia and nonobstructive coronary arteries","volume":"15","author":"Feenstra","year":"2022","journal-title":"Circ Cardiovasc Interv"},{"key":"2025110902421959900_ehaf580-B4","doi-asserted-by":"publisher","first-page":"35","DOI":"10.4244\/EIJ-D-24-00499","article-title":"Comprehensive diagnosis in chronic coronary syndromes combining angiography and intracoronary testing: the AID-ANGIO study","volume":"21","author":"Jer\u00f3nimo","year":"2025","journal-title":"EuroIntervention"},{"key":"2025110902421959900_ehaf580-B5","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1001\/jamacardio.2024.5670","article-title":"Safety, feasibility, and diagnostic yield of invasive coronary function testing: Netherlands registry of invasive coronary vasomotor function testing","volume":"10","author":"Crooijmans","year":"2025","journal-title":"JAMA Cardiol"},{"key":"2025110902421959900_ehaf580-B6","doi-asserted-by":"publisher","first-page":"e008126","DOI":"10.1161\/CIRCINTERVENTIONS.119.008126","article-title":"Ischemia and no obstructive coronary artery disease: prevalence and correlates of coronary vasomotion disorders","volume":"12","author":"Ford","year":"2019","journal-title":"Circ Cardiovasc Interv"},{"key":"2025110902421959900_ehaf580-B7","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1016\/j.jcin.2015.06.017","article-title":"Prevalence of coronary microvascular dysfunction among patients with chest pain and nonobstructive coronary artery disease","volume":"8","author":"Sara","year":"2015","journal-title":"JACC Cardiov Interv"},{"key":"2025110902421959900_ehaf580-B8","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1161\/CIRCULATIONAHA.114.012636","article-title":"Invasive evaluation of patients with angina in the absence of obstructive coronary artery disease","volume":"131","author":"Lee","year":"2015","journal-title":"Circulation"},{"key":"2025110902421959900_ehaf580-B9","doi-asserted-by":"publisher","first-page":"2841","DOI":"10.1016\/j.jacc.2018.09.006","article-title":"Stratified medical therapy using invasive coronary function testing in angina: the CorMicA trial","volume":"72","author":"Ford","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"2025110902421959900_ehaf580-B10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ahj.2025.03.004","article-title":"Rationale and design of the ILIAS ANOCA clinical trial: a blinded-arm controlled trial for routine ad-hoc coronary function testing","volume":"286","author":"Boerhout","year":"2025","journal-title":"Am Heart J"},{"key":"2025110902421959900_ehaf580-B11","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.jcin.2021.10.003","article-title":"Acetylcholine rechallenge: a first step toward tailored treatment in patients with coronary artery spasm","volume":"15","author":"Seitz","year":"2022","journal-title":"JACC Cardiovasc Interv"},{"key":"2025110902421959900_ehaf580-B12","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1001\/jamacardio.2020.7478","article-title":"Interpretation of the Seattle Angina Questionnaire as an outcome measure in clinical trials and clinical care: a review","volume":"6","author":"Thomas","year":"2021","journal-title":"JAMA Cardiol"},{"key":"2025110902421959900_ehaf580-B13","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1007\/s11136-011-9903-x","article-title":"Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L)","volume":"20","author":"Herdman","year":"2011","journal-title":"Qual Life Res"},{"key":"2025110902421959900_ehaf580-B14","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1093\/eurheartj\/ehae926","article-title":"Functional coronary assessment in angina with intermediate coronary stenosis: the #FullPhysiology approach","volume":"46","author":"Leone","year":"2025","journal-title":"Eur Heart J"},{"key":"2025110902421959900_ehaf580-B15","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.4244\/EIJ-D-21-00402","article-title":"Principles and pitfalls in coronary vasomotor function testing","volume":"17","author":"Feenstra","year":"2022","journal-title":"EuroIntervention"},{"key":"2025110902421959900_ehaf580-B16","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1056\/NEJMoa1916370","article-title":"Health-status outcomes with invasive or conservative care in coronary disease","volume":"382","author":"Spertus","year":"2020","journal-title":"N Engl J Med"},{"key":"2025110902421959900_ehaf580-B17","doi-asserted-by":"publisher","first-page":"1074969","DOI":"10.3389\/fcvm.2023.1074969","article-title":"Responsiveness and minimal clinically important difference of EQ-5D-5L in patients with coronary heart disease after percutaneous coronary intervention: a longitudinal study","volume":"10","author":"Zheng","year":"2023","journal-title":"Front Cardiovasc Med"},{"key":"2025110902421959900_ehaf580-B18","doi-asserted-by":"publisher","first-page":"132703","DOI":"10.1016\/j.ijcard.2024.132703","article-title":"Effects of radial artery spasm prophylaxis on intracoronary vasomotor responses during acetylcholine spasm provocation testing","volume":"419","author":"Sch\u00e4ufele","year":"2024","journal-title":"Int J Cardiol"}],"container-title":["European Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/46\/42\/4396\/64027141\/ehaf580.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/46\/42\/4396\/64027141\/ehaf580.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T07:42:24Z","timestamp":1762674144000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurheartj\/article\/46\/42\/4396\/8232491"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,12]]},"references-count":18,"journal-issue":{"issue":"42","published-online":{"date-parts":[[2025,8,12]]},"published-print":{"date-parts":[[2025,11,7]]}},"URL":"https:\/\/doi.org\/10.1093\/eurheartj\/ehaf580","relation":{},"ISSN":["0195-668X","1522-9645"],"issn-type":[{"value":"0195-668X","type":"print"},{"value":"1522-9645","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,11,7]]},"published":{"date-parts":[[2025,8,12]]}}}